JG
CCXI

Jefferies Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Jefferies Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,100
Closed -$70.1K – 2137
2021
Q3 		$70.1K Sell
4,100
-145,900
-97% -$2.27M ﹤0.01% 1579
2021
Q2 		$2.01M Buy
+150,000
New +$3.7M 0.01% 752
2020
Q2 		– Sell
-10,000
Closed -$402K – 2196
2020
Q1 		$402K Hold
10,000
– – ﹤0.01% 1396
2019
Q4 		$396K Buy
+10,000
New +$176K ﹤0.01% 1942

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jefferies Group's CCXI Position: Q3 2021 in Review

Jefferies Group sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 49,794 shares — an estimated $776K sold.

Jefferies Group first reported a position in CCXI in Q2 2013 and held it in 4 quarters. The position peaked at $667K in Q2 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Jefferies Group reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 49,794 ChemoCentryx, Inc. shares in Q3 2021, an estimated $776K.
  • Jefferies Group first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 4 quarters.
  • Jefferies Group's ChemoCentryx, Inc. position peaked at $667K in Q2 2021.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.